chr5-114404814-CATT-C
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_021614.4(KCNN2):c.1598_1600delTAT(p.Leu533del) variant causes a disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_021614.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNN2 | ENST00000673685.1 | c.1598_1600delTAT | p.Leu533del | disruptive_inframe_deletion | Exon 3 of 8 | NM_021614.4 | ENSP00000501239.1 | |||
KCNN2 | ENST00000512097.10 | c.1796_1798delTAT | p.Leu599del | disruptive_inframe_deletion | Exon 8 of 13 | 5 | ENSP00000427120.4 | |||
KCNN2 | ENST00000631899.2 | c.998_1000delTAT | p.Leu333del | disruptive_inframe_deletion | Exon 3 of 9 | 5 | ENSP00000487849.2 | |||
KCNN2 | ENST00000507750.5 | n.249+40816_249+40818delTAT | intron_variant | Intron 2 of 6 | 3 | ENSP00000516687.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Global developmental delay Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.962_964delTAT (p.L321del) alteration is located in coding exon 3 of the KCNN2 gene. This alteration consists of an in-frame deletion of 3 nucleotides at positions 962 and 964, resulting in the deletion of a leucine at amino acid position 321. Based on data from the Genome Aggregation Database (gnomAD), the KCNN2 c.962_964delTAT alteration was not observed, with coverage at this position. This alteration was described to occur de novo in a 2 year old female with motor and language delay (Mochel, 2020). The p.L321 amino acid is conserved in available vertebrate species. The p.L321 amino acid is located within the S5 transmembrane alpha helix that forms part of the central pore domain of the KCNN2 (SK2) protein (NCBI). Structrural modeling performed at Ambry Genetics indicates that this deletion will effectively cause all of the amino acids on the helix to be shifted over by one residue placing side chains into the center of the pore and likely blocking it (Long, 2005). The p.L321del alteration is predicted to be highly deleterious with a score of -12.344 by PROVEAN in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
KCNN2-related disorder Pathogenic:1
The KCNN2 c.962_964delTAT variant is predicted to result in an in-frame deletion (p.Leu321del). This variant was reported as de novo in an individual presenting with motor, language, and developmental delay without seizure or movement anomalies (Patient 4 in Mochel et al. 2020. PubMed ID: 33242881). Functional analysis showed that this variant lead to a reduced whole cell current when compared to wildtype KCNN2 (Mochel et al. 2020. PubMed ID: 33242881). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at